Suppression of autoantibodies to factor VIII and correction of factor VIII deficiency with a combined steroid-cyclophosphamide-porcine factor VIII treatment in a patient with rheumatoid arthritis

J Intern Med. 1992 Jun;231(6):617-9. doi: 10.1111/j.1365-2796.1992.tb01248.x.

Abstract

The presence of autoantibodies against factor VIII is an unusual but serious complication in rheumatoid arthritis. We describe the case of a patient who developed this kind of complication, with spontaneous bleeding and marked changes in the haematological parameters, that was unsuccessfully treated with a high dose of intravenous gammaglobulin. Subsequently, combined therapy with porcine factor VIII concentrate, cyclophosphamide and steroids led to the disappearance of the anti-factor VIII autoantibodies.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Arthritis, Rheumatoid / immunology*
  • Arthritis, Rheumatoid / therapy*
  • Autoantibodies / immunology*
  • Cyclophosphamide / therapeutic use*
  • Factor VIII / immunology*
  • Factor VIII / therapeutic use*
  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Prednisone / therapeutic use*

Substances

  • Autoantibodies
  • Immunoglobulins, Intravenous
  • Cyclophosphamide
  • Factor VIII
  • Prednisone